Health Trials

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions

ConditionHealthy Volunteers
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age19+
SponsorDaewoong Pharmaceutical Co. LTD.

About this trial

This study aims to evaluate the safety and pharmacokinetic characteristics of DWJ1622, DWC202313, and DWC202314 in healthy adult volunteers under fasting conditions.

Eligibility criteria

Qualifiers

Over 19 year old

Healthy adult volunteers

Disqualifiers

with a history of mental disorder

For female volunteers, those who are suspected of being pregnant or lactating

Trial design

Treatments tested in this trial

  • DWJ1622
  • DWC202313, DWC202314

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Daewoong Pharmaceutical Co. LTD.

Lead sponsor

Source ClinicalTrials.gov